Charting protein complexes, signaling pathways, and networks in the immune system

Immunological Reviews
Angela Bauch, Giulio Superti-Furga

Abstract

Systematic deciphering of protein-protein interactions has the potential to generate comprehensive and instructive signaling networks and to fuel new therapeutic and diagnostic strategies. Here, we describe how recent advances in high-throughput proteomic technologies, involving biochemical purification methods and mass spectrometry analysis, can be applied systematically to the characterization of protein complexes and the computation of molecular networks. The networks obtained form the basis for further functional analyses, such as knockdown by RNA interference, ultimately leading to the identification of nodes that represent candidate targets for pharmacological exploitation. No individual experimental approach can accurately elucidate all critical modulatory components and biological aspects of a signaling network. Such functionally annotated protein-protein interaction networks, however, represent an ideal platform for the integration of additional datasets. By providing links between molecules, they also provide links to all previous observations associated with these molecules, be they of genetic, pharmacological, or other origin. As exemplified here by the analysis of the tumor necrosis factor (TNF)-alpha/nuclear facto...Continue Reading

References

Apr 1, 1992·Immunology Today·S L Schreiber, G R Crabtree
Nov 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C T ChienS Fields
Mar 1, 1996·Analytical Chemistry·A ShevchenkoM Mann
May 23, 1998·Annual Review of Immunology·S GhoshE B Kopp
Jan 16, 1999·Molecular and Cellular Biology·F MercurioA M Manning
Apr 6, 1999·Trends in Biotechnology·W P Blackstock, M P Weir
May 18, 1999·The Journal of Allergy and Clinical Immunology·R C LevittN C Nicolaides
Jan 19, 2000·Trends in Genetics : TIG·J R Yates
Jun 3, 2000·Nature Genetics·G R BignellS Rasmussen
Sep 7, 2000·Current Opinion in Biotechnology·S P GygiR Aebersold
Mar 23, 2001·Nature Immunology·E MeffreM C Nussenzweig
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Mar 10, 2001·Cell·M Vidal
May 3, 2001·Nature·H JeongZ N Oltvai
Jun 8, 2001·The Journal of Biological Chemistry·S Van HuffelR Beyaert
Jun 14, 2001·Methods : a Companion to Methods in Enzymology·O PuigB Séraphin
Jul 19, 2001·Nature·C WangZ J Chen
Aug 8, 2001·Journal of Internal Medicine·M Baggiolini
Aug 8, 2001·The Journal of Cell Biology·B L DreesD G Drubin
Dec 18, 2001·Journal of Mass Spectrometry : JMS·J Peng, S P Gygi
Feb 28, 2002·Molecular Cell·Guoqing ChenDavid V Goeddel
Mar 26, 2002·Nature Reviews. Immunology·Amanda E I Proudfoot
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Patrick Aloy, Robert B Russell
May 31, 2002·The New England Journal of Medicine·Kevan C HeroldJeffrey A Bluestone
Jun 1, 2002·Science·Guoqing Chen, David V Goeddel
Jun 7, 2002·Nature·Christine QueitschSusan Lindquist
Jun 29, 2002·Science·Thomas Mitchell-Olds, Charles A Knight
Jul 4, 2002·Molecular & Cellular Proteomics : MCP·Raymond J DeshaiesJohn R Yates
Jul 9, 2002·EMBO Reports·Patrick AloyRobert B Russell
Jul 20, 2002·Trends in Molecular Medicine·Robert Z Orlowski, Albert S Baldwin

❮ Previous
Next ❯

Citations

Mar 28, 2009·Journal of Neurology·Robert H GoertschesUwe K Zettl
Oct 19, 2007·Cardiovascular Toxicology·Tomasz Lipniacki, Marek Kimmel
Sep 29, 2007·Nature Methods·Thomas Köcher, Giulio Superti-Furga
Sep 30, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Ed Croze
Dec 19, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Haiyang FangJing Zhao
Oct 24, 2007·FEBS Letters·Attila Becskei, Michael J Grusby
Feb 1, 2007·Expert Opinion on Drug Discovery·Paul A Whittaker
May 29, 2008·Journal of Cellular and Molecular Medicine·Francisco J QuintanaHoward L Weiner
Oct 11, 2008·Proteomics·Christian PreisingerWalter Kolch
Nov 1, 2012·Proteomics. Clinical Applications·Laura F DagleyAnthony W Purcell
Nov 19, 2013·Proteomics·Trevor Clancy, Eivind Hovig
Aug 29, 2006·Biochemical Pharmacology·Wim Vanden BergheGuy Haegeman
Oct 11, 2014·Biochimica Et Biophysica Acta·Florian Baumgart, Gerhard J Schütz
Dec 6, 2017·International Journal of Molecular Sciences·John Oliver NealonLiam James McGuffin
Jan 20, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Yvonne DöringChristian Weber
Jul 21, 2007·Proteomics·Tord BerggårdPeter James
Feb 26, 2008·Proteomics·Enrico PieroniAlberto de la Fuente
Feb 10, 2007·Expert Review of Proteomics·Xian ChenPengyuan Yang
Apr 10, 2010·Expert Review of Proteomics·Ellen Niederberger, Gerd Geisslinger
Apr 12, 2013·Expert Review of Proteomics·Ellen Niederberger, Gerd Geisslinger
Apr 19, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongliang ZuoXiaopeng Xu
Jan 13, 2015·Expert Review of Proteomics·Shachuan FengEdouard C Nice

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.